Search Results - "Kiss, Lajos Sandor"
-
1
High‐sensitivity C‐reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohn's disease: A marker for patient classification?
Published in Inflammatory bowel diseases (01-09-2012)“…Background: C‐reactive protein (CRP) is a traditional nonspecific marker of inflammation, with Crohn's disease (CD) being associated with a strong CRP…”
Get full text
Journal Article -
2
Natural history of ulcerative colitis: current knowledge
Published in Current drug targets (01-09-2011)“…The clinical presentation at the time of diagnosis and the disease course of ulcerative colitis (UC) are heterogeneous and variable over time. In…”
Get more information
Journal Article -
3
Anti-TNF trough levels and detection of antibodies to anti-TNF in inflammatory bowel disease: are they ready for everyday clinical use?
Published in Expert opinion on biological therapy (01-02-2012)“…In the last two decades, with the development of biological (anti-TNFα) therapy, the treatment paradigms for Crohn's disease and ulcerative colitis have…”
Get more information
Journal Article -
4
Evolution of disease phenotype in adult and pediatric onset Crohn's disease in a population-based cohort
Published in World journal of gastroenterology : WJG (2013)“…To investigate the evolution of disease phenotype in adult and pediatric onset Crohn's disease (CD) populations, diagnosed between 1977 and 2008. Data of 506…”
Get full text
Journal Article -
5
Serum lipopolysaccharide‐binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease
Published in Inflammatory bowel diseases (01-03-2011)“…Background: In inflammatory bowel disease (IBD), enhanced inflammatory activity in the gut is thought to increase the risk of bacterial translocation and…”
Get full text
Journal Article -
6
Tuberculin Skin Test and Quantiferon in BCG Vaccinated, Immunosuppressed Patients with Moderate-to-Severe Inflammatory Bowel Disease
Published in Journal of gastrointestinal and liver diseases : JGLD (01-12-2015)“…There are few data available on the effect of immunomodulator/biological therapy on the accuracy of the tuberculin skin test (TST) and interferon-gamma release…”
Get full text
Journal Article -
7
Klinikai és laboratóriumi faktorok szerepe a gyulladásos bélbetegségek lefolyásában és a terápiára adott válasz megítélésében
Published 01-01-2011“…Clinical, molecular and laboratory markers can help to predict clinically relevant relapses and long term disease course during the follow-up of inflammatory…”
Get full text
Dissertation -
8
Prediction of the disease course in inflammatory bowel diseases
Published in Orvosi hetilap (21-02-2010)“…Clinical presentation at diagnosis and disease course of both Crohn's disease (CD) and ulcerative colitis (UC) are heterogeneous and variable over time. During…”
Get more information
Journal Article -
9
Epidemiology, predictors and clinical aspects of loss of response to biological therapy
Published in Orvosi hetilap (05-02-2012)“…In the last two decades, the treatment paradigms for Crohn's disease and ulcerative colitis have significantly changed inclusive of a continuously increasing…”
Get more information
Journal Article -
10
Predictors of efficacy, mucosal healing and dose intensification during the first year of adalimumab therapy in patients with luminal and fistulizing Crohn's disease. National data from Hungary
Published in Orvosi hetilap (04-09-2011)“…Adalimumab is a fully human monoclonal antibody targeting tumor necrosis factor with proven efficacy in the treatment of Crohn's disease in clinical trials…”
Get more information
Journal Article